skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 21 - 40 of 902,968  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page
Show only
Refined by: subject: Oncology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
21
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study
Material Type:
Article 		Add to My Research

Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study

Journal of clinical oncology, 2020-01, Vol.38 (2), p.115-123 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.01488 ;PMID: 31682542

Full text available

Citations Cited by
22
The Critical Role of RNA m6A Methylation in Cancer
The Critical Role of RNA m6A Methylation in Cancer
Material Type:
Article 		Add to My Research

The Critical Role of RNA m6A Methylation in Cancer

Cancer research (Chicago, Ill.), 2019-04, Vol.79 (7), p.1285-1292 [Peer Reviewed Journal]

ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.CAN-18-2965

Full text available

Citations Cited by
23
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Material Type:
Article 		Add to My Research

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

Journal of clinical oncology, 2018-06, Vol.36 (16), p.1631-1641 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.76.8671 ;PMID: 29504847

Full text available

Citations Cited by
24
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma
Material Type:
Article 		Add to My Research

T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

Journal of clinical oncology, 2018-08, Vol.36 (22), p.2267-2280 [Peer Reviewed Journal]

2018 by American Society of Clinical Oncology 2018 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2018.77.8084 ;PMID: 29812997

Full text available

Citations Cited by
25
M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer
M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer
Material Type:
Article 		Add to My Research

M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer

Cancer research (Chicago, Ill.), 2019-01, Vol.79 (1), p.146-158 [Peer Reviewed Journal]

2018 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-18-0014 ;PMID: 30401711

Full text available

Citations Cited by
26
Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
Material Type:
Article 		Add to My Research

Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines

Annals of oncology, 2021-06, Vol.32 (6), p.801-805 [Peer Reviewed Journal]

2021 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2021.02.014 ;PMID: 33716105

Full text available

Citations Cited by
27
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Material Type:
Article 		Add to My Research

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade

Clinical cancer research, 2020-01, Vol.26 (2), p.487-504 [Peer Reviewed Journal]

2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-19-1868 ;PMID: 31636098

Full text available

Citations Cited by
28
Deep Learning Predicts Lung Cancer Treatment Response from Serial Medical Imaging
Deep Learning Predicts Lung Cancer Treatment Response from Serial Medical Imaging
Material Type:
Article 		Add to My Research

Deep Learning Predicts Lung Cancer Treatment Response from Serial Medical Imaging

Clinical cancer research, 2019-06, Vol.25 (11), p.3266-3275 [Peer Reviewed Journal]

2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-2495 ;PMID: 31010833

Full text available

Citations Cited by
29
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Material Type:
Article 		Add to My Research

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2016-09, Vol.27 (suppl 5), p.v38-v49 [Peer Reviewed Journal]

ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdw350 ;PMID: 27664260

Full text available

Citations Cited by
30
FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid Tumors
FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid Tumors
Material Type:
Article 		Add to My Research

FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid Tumors

Clinical cancer research, 2021-09, Vol.27 (17), p.4685-4689 [Peer Reviewed Journal]

2021 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-21-0327 ;PMID: 34083238

Full text available

Citations Cited by
31
Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors
Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors
Material Type:
Article 		Add to My Research

Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors

Cancer discovery, 2020-12, Vol.10 (12), p.1808-1825

ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.CD-20-0522 ;PMID: 33139244

Full text available

Citations Cited by
32
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
Material Type:
Article 		Add to My Research

SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma

Journal of clinical oncology, 2018-07, Vol.36 (19), p.1913-1921 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.76.0892 ;PMID: 29498924

Full text available

Citations Cited by
33
TIP: A Web Server for Resolving Tumor Immunophenotype Profiling
TIP: A Web Server for Resolving Tumor Immunophenotype Profiling
Material Type:
Article 		Add to My Research

TIP: A Web Server for Resolving Tumor Immunophenotype Profiling

Cancer research (Chicago, Ill.), 2018-12, Vol.78 (23), p.6575-6580 [Peer Reviewed Journal]

2018 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.CAN-18-0689 ;PMID: 30154154

Full text available

Citations Cited by
34
Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study
Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study
Material Type:
Article 		Add to My Research

Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study

Clinical cancer research, 2019-06, Vol.25 (12), p.3538-3547 [Peer Reviewed Journal]

2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-3190 ;PMID: 30842125

Full text available

Citations Cited by
35
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)
Material Type:
Article 		Add to My Research

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)

Journal of clinical oncology, 2022-09, Vol.40 (25), p.JCO2102660-2933 [Peer Reviewed Journal]

2022 by American Society of Clinical Oncology 2022 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.02660 ;PMID: 35576508

Full text available

Citations Cited by
36
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Material Type:
Article 		Add to My Research

T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

Clinical cancer research, 2018-09, Vol.24 (17), p.4175-4186 [Peer Reviewed Journal]

2018 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-17-1846 ;PMID: 29437767

Full text available

Citations Cited by
37
The Intersection between Tumor Angiogenesis and Immune Suppression
The Intersection between Tumor Angiogenesis and Immune Suppression
Material Type:
Article 		Add to My Research

The Intersection between Tumor Angiogenesis and Immune Suppression

Clinical cancer research, 2019-09, Vol.25 (18), p.5449-5457 [Peer Reviewed Journal]

2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-1543 ;PMID: 30944124

Full text available

Citations Cited by
38
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
Material Type:
Article 		Add to My Research

Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

Journal of clinical oncology, 2021-03, Vol.39 (7), p.840-859 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03237 ;PMID: 33405943

Full text available

Citations Cited by
39
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project
Material Type:
Article 		Add to My Research

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

Journal of clinical oncology, 2022-10, Vol.40 (29), p.JCO2102614-3418 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.21.02614 ;PMID: 35605179

Full text available

Citations Cited by
40
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
Material Type:
Article 		Add to My Research

Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

Cancer discovery, 2017-12, Vol.7 (12), p.1404-1419

2017 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.CD-17-0698 ;PMID: 29025771

Full text available

Citations Cited by

Results 21 - 40 of 902,968  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (800,015)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1964  (6,207)
  2. 1964 To 1978  (17,959)
  3. 1979 To 1993  (65,237)
  4. 1994 To 2009  (206,843)
  5. After 2009  (607,736)
  6. More options open sub menu

Resource Type 

  1. Articles  (900,213)
  2. Book Chapters  (2,299)
  3. Reviews  (189)
  4. Books  (171)
  5. Conference Proceedings  (79)
  6. magazinearticle  (17)
  7. More options open sub menu

Subject 

  1. Humans  (543,961)
  2. Female  (302,503)
  3. Male  (231,166)
  4. Middle Aged  (189,510)
  5. Tumors  (186,695)
  6. Biological And Medical Sciences  (180,243)
  7. Medical Sciences  (166,517)
  8. Aged  (154,019)
  9. Adult  (153,111)
  10. Animals  (152,620)
  11. Cancer  (123,896)
  12. Cancer Research  (109,934)
  13. Medicine  (105,942)
  14. Medicine & Public Health  (100,999)
  15. Prognosis  (98,193)
  16. Chemotherapy  (90,578)
  17. Mice  (88,783)
  18. More options open sub menu

Language 

  1. English  (902,173)
  2. Japanese  (119,873)
  3. Portuguese  (1,482)
  4. Polish  (865)
  5. Turkish  (702)
  6. Spanish  (684)
  7. Norwegian  (589)
  8. German  (516)
  9. Russian  (263)
  10. Korean  (249)
  11. French  (163)
  12. Chinese  (122)
  13. Slovenian  (25)
  14. Italian  (11)
  15. Afrikaans  (5)
  16. Dutch  (4)
  17. Danish  (2)
  18. Serbian  (1)
  19. Catalan  (1)
  20. Swedish  (1)
  21. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait